Posts Tagged ‘Pfizer-BioNTech’
2-dose, child-sized Pfizer vaccine authorized by FDA for 28 million children, 5 to 11. Vaccinations could begin next week.
The CDC will formalize the FDA’s Emergency Use recommendation of the Pfizer vaccine for children ages 5 through 11 this coming week. 28 million children (20% of population) will be eligible to receive the vaccine. The dose would be at a one-third strength and delivered in two shots, three weeks apart. Here is the statement…
Read MoreBREAKING: FDA approves Pfizer boosters for 65+ and high risk. Once CDC confirms, could start immediately.
The U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series in: individuals 65 years of age and older; individuals 18 through 64 years of age at…
Read MoreFDA Fully Approves First COVID-19 Vaccine – Pfizer, now known as Comirnaty
Note: Approx. 30% of those not vaccinated said they would become vaccinated as soon as the vaccine became approved. That just happened. Further approval should be given for Moderna soon. Booster shot approval should also be approved in the near future. Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine…
Read More